Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael E. Pape is active.

Publication


Featured researches published by Michael E. Pape.


Arteriosclerosis, Thrombosis, and Vascular Biology | 1991

Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein. Inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoprotein levels.

Michael E. Pape; E F Rehberg; Keith R. Marotti; George W. Melchior

A cDNA clone containing the coding region for cynomolgus monkey cholesteryl ester transfer protein (CETP) was isolated by the polymerase chain reaction with primers based on the human CETP cDNA sequence and cDNA synthesized from liver poly (A+) RNA. Analysis of that cDNA indicated that the nucleotide and amino acid sequences of cynomolgus monkey CETP were greater than 95% homologous with the human sequences. A fragment of the cDNA was used to develop an internal-standard/RNAse protection assay that allowed precise quantification of CETP mRNA levels. Analysis of total RNA from various tissues with this assay revealed that the liver and thoracic aorta expressed high levels of CETP mRNA; the mesenteric fat, adrenal gland, spleen, and abdominal aorta had low but detectable levels of the mRNA; and the brain, kidney, intestine, and skeletal muscle had undetectable levels of that mRNA. When the monkeys were made hypercholesterolemic by a high-fat, high-cholesterol (HFHC) diet, hepatic levels of CETP mRNA increased from 1.6 +/- 0.4 pg/micrograms total RNA (mean +/- SEM) to 4.1 +/- 0.8 pg/micrograms (p less than 0.005); mesenteric fat CETP mRNA increased from 0.4 +/- 0.1 pg/micrograms total RNA to 5.3 +/- 2.2 pg/micrograms (p less than 0.05); and plasma CET activity increased approximately fourfold. The CETP mRNA levels in the thoracic and abdominal aortas were not significantly increased in monkeys fed the HFHC diet, even though those animals had gross atherosclerosis. The apoprotein E mRNA levels, however, were markedly increased in the aortas of monkeys with atherosclerosis, with the largest increase occurring in the abdominal aorta. Taken together, these data suggest that lipid deposition in the artery was not accompanied by increased expression of the CETP gene in that tissue. Statistical analysis showed that a strong, negative correlation existed between hepatic CETP mRNA levels and both high density lipoprotein cholesterol (r = -0.85, p less than 0.001) and apoprotein A-I (r = -0.84, p less than 0.001). These data suggest that HFHC diet-induced changes in high density lipoprotein metabolism may be linked to altered expression of a function CETP gene.


Genetic Analysis: Biomolecular Engineering | 1991

mRNA quantitation by a simple and sensitive RNAse protection assay

Michael E. Pape; George W. Melchor; Keith R. Marotti

An RNAse protection assay is described that increases substantially the degree of precision with which one can measure the mRNA levels in cells and tissues through the use of the internal standard. The assay can be used to measure any mRNA for which the corresponding cDNA is available. We describe here the use of the assay to measure the apolipoprotein (apo)-A-I, apo-B, and apo-E mRNA levels in tissues from the cynomolgus monkey. cDNA fragments derived from each mRNA were subcloned into pGEM-9Zf(-), a vector containing a polylinker that is flanked by the SP6 and T7 RNA polymerase promoters. That series of plasmids, called RNA quantitation vectors (pRQV-AI, B, or E), permitted the synthesis of a sense RNA strand and an antisense RNA strand for the gene of interest. The sense stand was used as the internal standard and added to the RNA to be analyzed just prior to initiation of the assay. The radiolabeled antisense strand served as the probe. By including some nucleotides derived from the vector, we were able to design both the internal standard and the probe such that, after solution hybridization and RNAse digestion, the size of the protected internal standard-probe fragments was different from that of the authentic mRNA-probe fragments. Those fragments were then separated by gel electrophoresis, and the radioactivity in the authentic mRNA band was compared to that in the internal standard band. The mass of the authentic mRNA could then be calculated from the ratio of the radioactivity in each band and the mass of the internal standard.


Arteriosclerosis, Thrombosis, and Vascular Biology | 1997

Alcohol increases plasma levels of cholesterol diet-induced atherogenic lipoproteins and aortic atherosclerosis in rabbits.

Aviv Shaish; Michael E. Pape; Thomas D. Rea; Rai Ajit K. Srivastava; Mickey A. Latour; Dan Hopkins; Gustav Schonfeld

The purpose of the present study was to reexamine the relationship between alcohol and atherosclerosis. Two experiments were performed: The first contained three groups of New Zealand White (NZW) female rabbits. The control group was fed a cholesterol-containing liquid diet and the other two groups were fed the same diet with either 20% or 30% of the calories supplied by alcohol. The second experiment had two treatments: one control group and another group fed a 10% alcohol diet. In experiment 1, alcohol at the 20% and 30% levels increased VLDL and LDL but not HDL compared with levels in control rabbits. Hepatic mRNA levels of apolipoprotein (apo) A-I, apoB, and 7 alpha-hydroxylase were not affected by alcohol. However, the LDL-receptor mRNA was decreased to half of control values by either 20% or 30% alcohol. Lesion areas and aortic cholesterols were significantly increased in the 20% and 30% alcohol-treated groups. Also, significant correlations were found between plasma cholesterol levels and total lesion area or lesion cholesterol contents. In experiment 2, the 10% alcohol-treated rabbits showed no differences in circulating lipoproteins, LDL-receptor mRNA, or lesion formation above that observed in controls. These experiments suggest that alcohol substituted at 20% or 30% of the dietary calories induces hypercholesterolemia and more aortic atherosclerotic lesions. The alcohol-induced accumulation of VLDL and LDL was accompanied by low hepatic LDL-receptor mRNA levels, suggesting that alcohol may affect LDL-receptor expression and rates of lipoprotein clearance, but more experiments are needed to evaluate this possibility.


Biochimica et Biophysica Acta | 1991

Apo B metabolism in the cynomolgus monkey: evidence for post-transcriptional regulation

Michael E. Pape; Christine K. Castle; R.W. Murray; G.M. Funk; C.E. Hunt; Keith R. Marotti; George W. Melchior

Previous studies have shown that hepatic apo B mRNA levels do not increase in animals fed high cholesterol diets, even though plasma apo B concentrations increase markedly. As a result, it has been suggested that the diet-induced increase in plasma apo B levels was due solely to an inhibited clearance of those lipoproteins. The present study was undertaken to test that hypothesis. Hepatic apo B mRNA levels were measured in liver biopsies taken from five male cynomolgus monkeys before and twice after, they began to consume a high cholesterol diet. The diet had no effect on hepatic apo B mRNA levels, even though it caused a 7-fold increase in the plasma apo B levels. However, measurements of the apo B secretion rate in eight separate monkeys (four chow-fed and four cholesterol-fed) by isotope dilution showed that apo B secretion by the liver was increased 4-fold in the cholesterol-fed monkeys. These data, taken together, indicate that apo B secretion is not regulated by the rate at which the apo B gene is transcribed, but at some point further along in the secretion pathway.


Archive | 2000

Fourier transform mass spectrometry of complex biological samples

Jean-Louis Dasseux; Roger S. Newton; Thomas J. Rea; Charles L. Bisgaier; Michael E. Pape


Arteriosclerosis, Thrombosis, and Vascular Biology | 1997

Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo Into Two Distinct Hepatic Metabolic Pools Implications for the Treatment of Atherosclerosis

Wendi V. Rodrigueza; Kirstin D. Mazany; Arnold D. Essenburg; Michael E. Pape; Thomas J. Rea; Charles L. Bisgaier; Kevin Jon Williams


Journal of Lipid Research | 1991

Secretion of pre-beta-migrating apoA-I by cynomolgus monkey hepatocytes in culture.

Christine K. Castle; Michael E. Pape; Keith R. Marotti; George W. Melchior


Archive | 2003

Methods and compositions for the treatment of ischemic reperfusion

Charles L. Bisgaier; Michael E. Pape; Jan Johansson; Guido Franceschini


Journal of Lipid Research | 1994

Rabbit liver apolipoprotein A-I synthesis is under nonparenchymal cell paracrine control.

Thomas J. Rea; Charles L. Bisgaier; Ronald B. DeMattos; Michael E. Pape


Journal of Medicinal Chemistry | 2004

Long Hydrocarbon Chain Ether Diols and Ether Diacids That Favorably Alter Lipid Disorders in Vivo

Ralf Mueller; Jing Yang; Caiming Duan; Emil Pop; Lian Hao Zhang; Tian-Bao Huang; Anna Denisenko; Olga V. Denisko; Daniela C. Oniciu; Charles L. Bisgaier; Michael E. Pape; Catherine Delaney Freiman; Brian Goetz; Clay T. Cramer; Krista L. Hopson; Jean-Louis Dasseux

Collaboration


Dive into the Michael E. Pape's collaboration.

Top Co-Authors

Avatar

Clay T. Cramer

Esperion Therapeutics Inc.

View shared research outputs
Top Co-Authors

Avatar

Daniela C. Oniciu

Esperion Therapeutics Inc.

View shared research outputs
Top Co-Authors

Avatar

Emil Pop

University of Florida

View shared research outputs
Top Co-Authors

Avatar

Brian Goetz

Esperion Therapeutics Inc.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Krista L. Hopson

Esperion Therapeutics Inc.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge